Results 181 to 190 of about 27,181 (268)

Understanding the Housing and Support Experience of People With Complex Disability in Australia: A Qualitative Analysis of Submissions to the Disability Royal Commission

Australian Journal of Social Issues, Volume 61, Issue 2, Page 344-357, June 2026.
ABSTRACT In 2019, the Australian government established the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (‘Disability Royal Commission’, DRC) to investigate widespread mistreatment of people with disability. Nearly 10,000 people with disability, their families and supporters engaged with the DRC.
Kate D'Cruz, Fiona Carey, Libby Witts, Jessie Spence, Peter Mulherin, Megan Topping, Di Winkler, Jacinta Douglas   +7 more
wiley   +1 more source

Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study. [PDF]

Blood Adv
Autore F, Tedeschi A, Benevolo G, Danesin N, Giannarelli D, Rizzi R, Cencini E, Mattiello V, Ferrarini I, Pasquale R, Del Giudice I, Ferrari A, Bullo M, Rossini B, Motta M, Marino D, Innocenti I, Stirparo L, Petrilli D, Musto P, Peri V, Zamprogna G, Hohaus S, Frustaci AM, Piazza F, Ferrero S, Laurenti L.   +26 more
europepmc   +1 more source

Characterizing treatment initiation with central nervous system–active polypharmacy among adults with dementia

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Central nervous system (CNS) –active polypharmacy, defined as concurrent use of antidepressants, antipsychotics, anti‐seizure medications, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonists, opioids, or skeletal muscle relaxants for ≥ 31 consecutive days, poses significant risks patients with dementia.
Donovan T. Maust, Rachel C. Davis, Julie Strominger, Steven C. Marcus, Hyungjin Myra Kim, Tanner Caverly, Frederic C. Blow, Lauren P. Wallner, Sarah Krein, Sarah E. Vordenberg   +9 more
wiley   +1 more source

Polymerizable inhibitor can reduce shrinkage stress of resin composite. [PDF]

Clin Oral Investig
He J, Garoushi S, Lassila L, Vallittu PK.   +3 more
europepmc   +1 more source

Main factors associated with variability in the assessment of the objective response rate. A re‐analysis of the PHEREXA phase 3 clinical trial

British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1894-1901, June 2026.
Abstract Aim Local investigators (LIs) overestimate the objective response rate (ORR) in comparison to Blinded Independent Central Reviewers (BICR) in oncology. In this study, we re‐analysed data obtained in the PHEREXA trial (NCT01026142) with the following aims: i) to confirm at the single‐patient level the discrepancy observed by analysing ...
Gennaro Daniele, Tommaso Giovagnoli, Pierluigi Navarra, Cinzia Dello Russo   +3 more
wiley   +1 more source

Mpox (Monkeypox) in Pregnant Women, the Placenta and Fetus: Correlation with Maternal-Fetal Transmission, Pathology and Strain Differences from MPXV Clades Ia, Ib, IIa, and IIb. [PDF]

Viruses
Schwartz DA.
europepmc   +1 more source

Cohort profile: a community‐based prospective cohort study of Alzheimer's disease and related dementias in the Democratic Republic of Congo

Alzheimer's &Dementia: Behavior &Socioeconomics of Aging, Volume 2, Issue 2, June 2026.
Abstract INTRODUCTION The Étude du Vieillissement Cognitif et de Démence en République Démocratique du Congo (EVCD‐RDC) launched in 2024 to investigate socio‐environmental and biological determinants of dementia in Kinshasa. METHODS The study recruited 1000 adults aged ≥65 years across four diagnostic groups – cognitively unimpaired (CU), mild ...
Jean Ikanga, Caterina Obenauf, Saranya Sundaram Patel, Megan Schwinne, Guy Gikelekele, Emmanuel Epenge, Japhet Magolu Potshi, Topina Tomadia, Julie Kazadi, Immaculee Kavugho, Giovanni Luamba Santolini, Aristote Nkosi, Francine Manyonga Sabowa, Brenda Matungu Musewu, Elipsis Mawisa, Joseph Phuati Tsangu, Francis Muena Kondo Beya, Samuel Mampunza, Lelo Mananga, Justine Bukabau, Charlotte E. Teunissen, Thomas Karikari, Alden L. Gross, Julio C. Rojas, Alvaro Alonso   +24 more
wiley   +1 more source

Understanding the Rift Valley fever exposure risk: A comparative perspective from a multi-country study in East and Central Africa, 2021-24. [PDF]

PLoS Negl Trop Dis
Lepore L, Odinoh R, Dawa J, Situma S, Nyakarahuka L, Makiala S, Viala H, Ifufa C, Muhindo MK, Kayiwa J, Awor N, Mulopo-Mukanya N, Tumusiime A, Hauner A, Kyondo J, Rogé S, Nasimiyu C, Kisembo S, Namutebi A, Odong D, Kavunga-Membo H, Lutwama J, Mulinda ÉB, Ariën KK, Mukadi-Bamuleka D, Ndumu D, Tamfum JM, Breiman RF, Bakamutumaho B, Njenga K, Masumu J, Vanlerberghe V.   +31 more
europepmc   +1 more source

Maxillofacial Cemento‐Ossifying Fibroma: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Cemento‐ossifying fibroma is a relatively rare lesion affecting the jaws, especially the anterior mandible. The most common clinical presentation is swelling. Diagnosis based on clinical observation only is challenging. Radiological images and histological findings can be misleading due to similitudes with other osteo‐fibrous lesions.
Alix N. Kamina, Elisée Ntambua Mbombo, Patrick Badibanga, Christian Tague, Pascal Lutumba, Criss Koba Mjumbe   +5 more
wiley   +1 more source

Mpox vaccine acceptance and uptake in Africa: a systematic review and meta-analysis. [PDF]

BMC Glob Public Health
Cheuyem FZL, Njoh AA, Achangwa C, Kistner O, Tchamani R, Goupeyou-Youmsi J, Takpangdo-Le-Grand DR, Kourouma S, Temgoua MN.   +8 more
europepmc   +1 more source